To be launched immediately
Strides Arcolab announced that it has received approval from the United States Food & Drug Adminstration (USFDA) for Benzonatate Softgel Capsules USP, 100 mg and 200 mg.According to IMS date, the US market for Benzonatate is approximately USD 41 million.
The product will be manufactured at the Company's Oral dosage facility at Bangalore and marketed by Strides in the US market. The product will be launched immediately.
Powered by Capital Market - Live News
